Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract PD9-05: Prognostic and tamoxifen-predictive effect of PAM50 and ROR score in premenopausal women included in the randomised SBII:2 trial

Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén

Cancer Res (2022) 82 (4_Supplement): PD9-05.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD9-05

Published: 15 February 2022

View article

Journal Articles

Abstract PS5-09: Tumour infiltrating lymphocytes of prognostic value in different molecular breast cancer subgroups and as a suggestive predictive factor for adjuvant tamoxifen benefit in premenopausal patients after 30 years follow-up

Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén

Cancer Res (2021) 81 (4_Supplement): PS5-09.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS5-09

Published: 15 February 2021

View article

Journal Articles

Abstract P6-05-09: G protein-coupled estrogen receptor expressed in the plasma membrane is associated with worse breast cancer outcome, but does not contribute to tamoxifen resistance

Julia Tutzauer, Martin Sjöström, Pär-Ola Bendahl, Lisa Rydén, Mårten Fernö, Fredrik Leeb-Lundberg, Sara Alkner

Cancer Res (2020) 80 (4_Supplement): P6-05-09.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P6-05-09

Published: 15 February 2020

View article

Journal Articles

Abstract P4-01-04: The distribution and prognostic significance of circulating tumor cells are different in invasive lobular carcinoma compared to invasive ductal carcinoma of the breast

Ulrik Christoffer Narbe, Pär-Ola Bendahl, Kristina Aaltonen, Mårten Fernö, Carina Forsare, Charlotte Levin Tykjær Jørgensen, Anna-Maria Larsson, Lisa Rydén

Cancer Res (2020) 80 (4_Supplement): P4-01-04.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P4-01-04

Published: 15 February 2020

View article

Journal Articles

Abstract P3-08-21: High CYP27A1 expression at protein and transcript level predicts favorable outcome in node negative, premenopausal breast cancer

Maria Inasu, Pär Ola Bendahl, Mårten Fernö, Per Malmström, Signe Borgquist, Siker Kimbung

Cancer Res (2020) 80 (4_Supplement): P3-08-21.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P3-08-21

Published: 15 February 2020

View article

Journal Articles

Abstract P3-08-08: Prognostic and predictive impact of stroma cells defined by platelet derived growth factor receptor beta in early breast cancer: Results from the randomized SweBGR91RT trial

Carina Strell, Reidunn J Edelmann, Axel Stenmark Tullberg, Per Malmström, Mårten Fernö, Arne Östman, Erik Holmberg, Per Karlsson

Cancer Res (2020) 80 (4_Supplement): P3-08-08.

DOI: https://doi.org/10.1158/1538-7445.SABCS19-P3-08-08

Published: 15 February 2020

View article

Journal Articles

Abstract P6-08-43: Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013

Anna Ehinger, Per Malmström, Pär-Ola Bendahl, Christopher W Elston, Anna-Karin Falck, Carina Forsare, Dorthe Grabau, Lisa Rydén, Olle Stål, Mårten Fernö

Cancer Res (2015) 75 (9_Supplement): P6-08-43.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P6-08-43

Published: 01 May 2015

View article

Journal Articles

Abstract P6-08-03: Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer

Siker Kimbung, Ida Johansson, Anna Danielsson, Srinivas Veerla, Suzanne Egyhazi, Jonas Bergh, Zakaria Einbeigi, Barbro Linderholm, Elisabet Lidbrink, Niklas Loman, Per Malmström, Martin Söderberg, Thomas M Walz, Mårten Fernö, Thomas Hatschek, Ingrid Hedenfalk, the TEX Study Group

Cancer Res (2015) 75 (9_Supplement): P6-08-03.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P6-08-03

Published: 01 May 2015

View article

Journal Articles

Abstract P1-12-17: Mature data (> 25 years) on 2 years adjuvant tamoxifen treatment in premenopausal women with breast cancer: Time to re-emphasize the progesterone receptor as predictive factor?

Maria Ekholm, Pär-Ola Bendahl, Mårten Fernö, Bo Nordenskjöld, Olle Stål, Lisa Rydén

Cancer Res (2015) 75 (9_Supplement): P1-12-17.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P1-12-17

Published: 01 May 2015

View article

Journal Articles

Abstract P3-11-14: Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer? Clinical results from a neoadjuvant trial using a combination of epirubicin, docetaxel and bevacizumab (PROMIX)

Thomas Hatschek, Judith Bjöhle, Elisabet Lidbrink, Tobias Lekberg, Niklas Loman, Anna von Wachenfeldt Väppling, Martin Söderberg, Zakaria Einbeigi, Lena Carlsson, Henrik Lindman, Irma Fredriksson, Jan Frisell, Lars Löfgren, Lisa Rydén, Mats Hellström, Mårten Fernö, Jonas Bergh

Cancer Res (2015) 75 (9_Supplement): P3-11-14.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P3-11-14

Published: 01 May 2015

View article

Journal Articles

Abstract P5-02-02: Central testing of ER, PR, HER2, and Ki67, routinely analyzed at 27 pathology departments in Sweden – Potential consequences for the choice of adjuvant therapy

Maria Ekholm, Dorthe Grabau, Per-Ola Bendahl, Göran Elmberger, Hans Olsson, Leila Russo, Guiseppe Viale, Mårten Fernö

Cancer Res (2015) 75 (9_Supplement): P5-02-02.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P5-02-02

Published: 01 May 2015

View article

Journal Articles

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance

Susann Busch, Andrew H. Sims, Olle Stål, Mårten Fernö, Göran Landberg

Cancer Res (2015) 75 (7): 1457–1469.

DOI: https://doi.org/10.1158/0008-5472.CAN-14-1583

Published: 31 March 2015

View article

Includes: Supplementary data

Journal Articles

Abstract B58: Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences

Siker Kimbung, Mårten Fernö, Per Malmström, Thomas Hatschek, Ingrid Hedenfalk

Cancer Res (2013) 73 (3_Supplement): B58.

DOI: https://doi.org/10.1158/1538-7445.TIM2013-B58

Published: 01 May 2014

View article

Journal Articles

The Retinoblastoma Gene Undergoes Rearrangements in BRCA1-Deficient Basal-like Breast Cancer

Cancer Res (2012) 72 (16): 4028–4036.

DOI: https://doi.org/10.1158/0008-5472.CAN-12-0097

Published: 14 August 2012

View article

Includes: Supplementary data

Journal Articles

Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1

Jeanette Nilsson, Khalil Helou, Anikó Kovács, Pär-Ola Bendahl, Gunnar Bjursell, Mårten Fernö, Peter Carlsson, Marie Kannius-Janson

Cancer Res (2010) 70 (5): 2020–2029.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-1677

Published: 28 February 2010

View article

Includes: Multimedia, Supplementary data

Journal Articles

HER-2/neu Amplification Predicts Poor Survival in Node-positive Breast Cancer

Åke Borg, Atul K. Tandon, Helgi Sigurdsson, Gary M. Clark, Mårten Fernö, Suzanne A. W. Fuqua, Dick Killander, William L. McGuire

Cancer Res (1990) 50 (14): 4332–4337.

Published: 01 July 1990

View article

NARROW

Abstract PD9-05: Prognostic and tamoxifen-predictive effect of PAM50 and ROR score in premenopausal women included in the randomised SBII:2 trial

Abstract PS5-09: Tumour infiltrating lymphocytes of prognostic value in different molecular breast cancer subgroups and as a suggestive predictive factor for adjuvant tamoxifen benefit in premenopausal patients after 30 years follow-up

Abstract P6-05-09: G protein-coupled estrogen receptor expressed in the plasma membrane is associated with worse breast cancer outcome, but does not contribute to tamoxifen resistance

Abstract P4-01-04: The distribution and prognostic significance of circulating tumor cells are different in invasive lobular carcinoma compared to invasive ductal carcinoma of the breast

Abstract P3-08-21: High CYP27A1 expression at protein and transcript level predicts favorable outcome in node negative, premenopausal breast cancer

Abstract P3-08-08: Prognostic and predictive impact of stroma cells defined by platelet derived growth factor receptor beta in early breast cancer: Results from the randomized SweBGR91RT trial

Abstract P6-08-43: Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013

Abstract P6-08-03: Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer

Abstract P1-12-17: Mature data (> 25 years) on 2 years adjuvant tamoxifen treatment in premenopausal women with breast cancer: Time to re-emphasize the progesterone receptor as predictive factor?

Abstract P3-11-14: Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer? Clinical results from a neoadjuvant trial using a combination of epirubicin, docetaxel and bevacizumab (PROMIX)

Abstract P5-02-02: Central testing of ER, PR, HER2, and Ki67, routinely analyzed at 27 pathology departments in Sweden – Potential consequences for the choice of adjuvant therapy

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance

Abstract B58: Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences

The Retinoblastoma Gene Undergoes Rearrangements in BRCA1-Deficient Basal-like Breast Cancer

Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1

HER-2/neu Amplification Predicts Poor Survival in Node-positive Breast Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only